SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-21-000016
Filing Date
2021-05-06
Accepted
2021-05-06 16:45:57
Documents
83
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20210331.htm   iXBRL 10-Q 1451180
2 EX-31.1 ex03312021311.htm EX-31.1 12784
3 EX-31.2 ex03312021312.htm EX-31.2 12458
4 EX-32.1 ex03312021321.htm EX-32.1 8839
5 EX-32.2 ex03312021322.htm EX-32.2 8909
11 tvtx-20210331_g1.gif GRAPHIC 246868
  Complete submission text file 0001438533-21-000016.txt   7455189

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20210331.xsd EX-101.SCH 44682
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20210331_cal.xml EX-101.CAL 105429
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20210331_def.xml EX-101.DEF 238063
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20210331_lab.xml EX-101.LAB 556753
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20210331_pre.xml EX-101.PRE 383029
12 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20210331_htm.xml XML 1096004
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 21898606
SIC: 2834 Pharmaceutical Preparations